LYDIA PRUSINOWSKI: Open Payments
NPI 1528378817 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $1,268
Food & beverage: $1,068Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $264 |
| ABBVIE INC. | 8 | $239 |
| Arcutis Biotherapeutics, Inc. | 3 | $229 |
| GENZYME CORPORATION | 3 | $174 |
| Novartis Pharmaceuticals Corporation | 2 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| UCB, Inc. | 2 | $40 |
| ConvaTec Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: DUPIXENT, TREMFYA, Zoryve, RINVOQ, SKYRIZI, Bimzelx, Rhapsido, INNOVAMATRIX AC.
Industry payments across CO — which companies pay providers there.
